The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Wall St advances, dollar declines as remarkable year nears finish line

Wed, 30th Dec 2020 16:05

* All three major U.S. stock averages higher

* Dollar sinks to lowest since April 2018

* Stimulus check negotiations continue in Washington

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh
(Updates to U.S. market open, changes dateline to NEW YORK (was
LONDON), changes byline)

By Stephen Culp

NEW YORK, Dec 30 (Reuters) - Wall Street advanced and the
dollar dipped to its lowest in more than two years on Wednesday,
the penultimate trading day in an extraordinary year of
pandemic, recession and recovery.

All three major U.S. stock indexes were up in a broad rally,
as impending stimulus and the ongoing rollout of COVID-19
vaccines fed optimism over economic recovery in 2021.

"I would caution against reading too much into trading
action this week because it's a shortened week and volumes are
typically down, so there tends to be more volatility," said
Chuck Carlson, chief executive officer at Horizon Investment
Services in Hammond, Indiana.

"The dollar is a continuation of what we've seen in the last
few months," Carlson added. "This is partly in anticipation that
since Europe had a deeper decline, its rebound will have more of
a snap-back."

U.S. Senate Majority Leader Mitch McConnell introduced a
bill late Tuesday that combines beefier $2,000 direct fiscal aid
payments to Americans with provisions involving social media
company protections and election security.

Britain approved a coronavirus vaccine developed by Oxford
University and AstraZeneca in the latest development in
the rapid progression, testing, approval and deployment of drugs
to battle the disease.

The Dow Jones Industrial Average rose 165.7 points,
or 0.55%, to 30,501.37, the S&P 500 gained 13.87 points,
or 0.37%, to 3,740.91 and the Nasdaq Composite added
34.01 points, or 0.26%, to 12,884.23.

European stocks reversed gains and headed slightly lower as
investors took profits in the wake of strong gains.

The pan-European STOXX 600 index lost 0.13% and
MSCI's gauge of stocks across the globe gained
0.49%.

Emerging market stocks rose 1.58%. MSCI's broadest index of
Asia-Pacific shares outside Japan closed 1.67%
higher, while Japan's Nikkei lost 0.45%.

U.S. Treasury yields were essentially flat on Wednesday
morning in thin trading as investors bet that Republicans were
unlikely to approve the passage of proposed $2000 stimulus
checks.

Benchmark 10-year notes last fell 1/32 in price
to yield 0.9364%, from 0.935% late on Tuesday.

The 30-year bond last fell 4/32 in price to
yield 1.679%, from 1.674% late on Tuesday.

The dollar fell the lowest since April 2018 against a basket
of world currencies as investors bet on more fiscal support and
positioned for year-end in light trading volume.

The dollar index fell 0.41%, with the euro up
0.36% to $1.2291.

The Japanese yen strengthened 0.42% versus the greenback at
103.15 per dollar, while Sterling was last trading at
$1.3608, up 0.80% on the day.

Crude oil prices gained ground on the back of the weaker
dollar and a dip in U.S. inventories.

U.S. crude rose 1.27% to $48.61 per barrel and Brent
was last at $51.33, up 0.47% on the day.

Gold gained ground as the safe-haven metal countered a dip
in the greenback.

Spot gold added 0.3% to $1,884.41 an ounce.

(Editing by Larry King and Nick Zieminski)

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.